Shanghai MicroPort MedBot (Group) Co., Ltd. Share Price

Equities

2252

CNE100004QP1

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 09:08:27 12/07/2024 BST 5-day change 1st Jan Change
8.68 HKD +2.24% Intraday chart for Shanghai MicroPort MedBot (Group) Co., Ltd. +2.12% -58.37%

Financials

Sales 2024 * 225M 31M 242M 2.39B Sales 2025 * 697M 96.1M 750M 7.41B Capitalization 7.78B 1.07B 8.37B 82.63B
Net income 2024 * -686M -94.56M -738M -7.29B Net income 2025 * -513M -70.71M -552M -5.45B EV / Sales 2024 * 35.9 x
Net Debt 2024 * 295M 40.65M 317M 3.13B Net Debt 2025 * 793M 109M 853M 8.42B EV / Sales 2025 * 12.3 x
P/E ratio 2024 *
-11.9 x
P/E ratio 2025 *
-17.1 x
Employees 646
Yield 2024 *
-
Yield 2025 *
-
Free-Float 25.87%
More Fundamentals * Assessed data
Dynamic Chart
MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue MT
MicroPort MedBot Raises HK$114 Million from Share Placement MT
Shanghai Microport Medbot Co., Ltd. Provides Revenue Guidance for the Six Months Ended June 30, 2024 CI
Shanghai MicroPort MedBot Co., Ltd. Announces Resignation of Mui Wing Hong as an Independent Non-Executive Director, Chairperson of the Audit Committee and A Member of the Nomination Committee, Effective 18 July 2024 CI
Hong Kong Stocks Plunge After 2 Days in Green; Shanghai MicroPort MedBot Stocks Plummet 19% MT
Shanghai MicroPort MedBot Plans Issuance of 12.9 Million Shares; Shares Fall 18% MT
Shanghai MicroPort MedBot Unit Signs Sale-Lease Back Deal for Surgery Navigation System Prototypes; Shares Jump 5% MT
EU Grants CE Mark to Shanghai Medbot's Laparoscopic Surgical Robot MT
Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Microport Medbot Co., Ltd. Provides Group Earnings Guidance for the Year Ended December 31, 2023 CI
Shanghai MicroPort MedBot Co., Ltd. Approves Board Elections CI
China Approves Surgical Robot Developed by Microport MedBot-Robocath JV MT
Shanghai Microport MedBot Gets Thumbs Up to Launch Toumai Surgical Robot MT
Shanghai Microport Medbot Co., Ltd. Announces Toumai Laparoscopic Surgical Robot Obtains Approval from the National Medical Products Administration of China for Multidisciplinary Registration CI
China Approves Launch of MedBot's Orthopedic Surgical Robot MT
More news
1 day+2.24%
1 week+2.12%
Current month-1.48%
1 month-29.77%
3 months-31.33%
6 months-47.07%
Current year-58.37%
More quotes
1 week
8.19
Extreme 8.19
8.73
1 month
8.19
Extreme 8.19
12.68
Current year
8.19
Extreme 8.19
21.35
1 year
8.19
Extreme 8.19
23.00
3 years
8.19
Extreme 8.19
73.45
5 years
8.19
Extreme 8.19
73.45
10 years
8.19
Extreme 8.19
73.45
More quotes
Managers TitleAgeSince
President 40 17/10/17
Comptroller/Controller/Auditor 45 31/05/22
Human Resources Officer 46 28/02/21
Members of the board TitleAgeSince
Chairman 48 02/04/20
Director/Board Member 41 16/09/20
President 40 17/10/17
More insiders
Date Price Change Volume
12/07/24 8.68 +2.24% 1,028,187
11/07/24 8.49 +2.54% 1,116,278
10/07/24 8.28 -0.24% 556,776
09/07/24 8.3 -3.15% 2,647,800
08/07/24 8.57 +0.82% 1,185,500

Delayed Quote Hong Kong S.E., July 12, 2024 at 09:08 am

More quotes
Shanghai MicroPort Medical Robot Group Co Ltd is a company engaged in the development of surgical instruments. The Company's main business is the design, development and commercialization of innovative surgical robots. The Company's products include Toumai Laparoscopic Surgical Robot, DFVision 3D Electronic Laparoscope and Honghu Orthopedic Surgical Robot. The Company's surgical robots are used in multiple minimally invasive surgery fields, including endoscopic surgery, orthopedic surgery, pan-vascular surgery, natural cavity surgery and percutaneous puncture surgery. In addition, the Company also provides education and training services for its surgical robot MedBot.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.06 CNY
Average target price
21.26 CNY
Spread / Average Target
+163.78%
Consensus

Annual profits - Rate of surprise